BASF 483 Covers Cleaning, Quality Unit Issues

Active pharmaceutical ingredient (API) manufacturer BASF was handed an FDA Form 483 for observations related to cleaning procedures, test equipment calibration and document adherence. The FDA’s New Jersey District Office made five observations during a March 9 to 22 inspection of BASF’s Washington, N.J., facility, including finding that “cleaning procedures are not validated.”
Drug GMP Report